Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer

Clinical trial NCT07188246 · RECRUITING

Trial details

NCT number: NCT07188246
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Cancer Stage II Breast Cancer Stage III Breast Cancer Invasive Breast Cancer Triple Negative

Start date: 2026-01-19
Primary completion: 2027-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.